As of 2024-07-27, the Relative Valuation of Antares Pharma Inc (ATRS) is 7.18 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 28.5%.
The range of the Relative Valuation is 5.63 - 9.02 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 16.9x - 27.1x | 21.5x |
| Fair Price | 5.63 - 9.02 | 7.18 |
| Upside | 0.7% - 61.4% | 28.5% |
| Date | P/E |